Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers
| Autor: | N Ulliac, M.C. Perault, I Zieleniuk, Alain Patat, P Rosenzweig, B. Vandel |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
Adult
Male Anterograde amnesia Sedation Flicker fusion threshold Lorazepam Placebo Cognition Double-Blind Method Memory medicine Humans Drug Interactions Pharmacology (medical) Pharmacology Analysis of Variance Cross-Over Studies business.industry Repeated measures design Free recall Anesthesia Histamine H1 Antagonists Benzimidazoles medicine.symptom business Psychomotor Performance Research Article medicine.drug Mizolastine |
| Zdroj: | British Journal of Clinical Pharmacology. 39:31-38 |
| ISSN: | 0306-5251 |
| Popis: | 1. The possible interaction between a new H1 antihistamine, mizolastine, and lorazepam was assessed in a randomised, double-blind, cross-over, placebo-controlled study involving 16 healthy young male volunteers who received mizolastine 10 mg or placebo once daily for 8 days with a 1 week wash-out interval. The interaction of mizolastine, at steady-state, with a single oral dose of lorazepam or placebo was assessed on days 6 or 8 of each treatment period. 2. Psychomotor performance and cognitive function were evaluated using objective tests (critical flicker fusion threshold, choice reaction time, tapping, arithmetic calculation, body sway) and self-ratings (visual analogue scale, ARCI) before and at 2, 4, 6 and 8 h after dosing. Short-term memory (Sternberg memory scanning immediate free recall of a word list) and long-term memory (delayed free recall and recognition of words and pictures) were assessed before and at 3 h after dosing. Pharmacodynamic interactions were evaluated by repeated measures ANOVA in a 2 x 2 factorial interaction model. 3. Mizolastine, 10 mg once daily, at steady-state, was devoid of sedation and detrimental effect on skilled performance and memory. 4. In contrast, a single 2 mg dose of lorazepam produced marked impairment of psychomotor performance, cognitive functions (significant reduction in flicker fusion threshold, tapping and arithmetic calculation and increase in reaction times and body sway) and subjective sedation from 2 to 8 h after dosing. In addition, lorazepam induced an anterograde amnesia, characterised by a decrease in delayed free recall and recognition, and a deficit in short term memory.(ABSTRACT TRUNCATED AT 250 WORDS) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text